PISCATAWAY, N.J. — Camber Pharmaceuticals on Thursday announced that it had launched antipsychotic drug aripiprazole — a generic version of Abilify — in 2-, 5-, 10-, 15-, 20- and 30-mg strength tablets.
Aripiprazole is used to treat schizophrenia, which affects about 1% of the population, and bipolar disorder. The
FDA approved the first round of the generic in late April.